德国拜耳维立西呱价格多少?
How much does Bayer Vericiguat cost in Germany?
Veliciguat was jointly developed and promoted by Bayer and Merck. It was approved for marketing by the US FDA in 2021 and by China's NMPA in May 2022. Affected by exchange rate fluctuations in overseas markets, drug prices are not fixed. The current reference prices are as follows:
German direct mail version of Veliciguat from Bayer Pharmaceuticals:
A box of 98 tablets, the price of 10mg is about 5500;
A box of 98 tablets, the price of 5mg is about 5,000;
A box of 28 tablets, 2.5mg, the price is about 2,500.
Patients who need the German version of Veciguat can go to Germany to buy it, but the risk is high and there is no guarantee of authenticity. Moreover, it is inconvenient for many patients to go abroad. At this time, they can also obtain it through domestic professional overseas medical service institutions. Veciguat can be directly mailed to your home from Germany, and you can obtain overseas drugs without leaving home. You can also sign a drug purchase contract to ensure that it is genuine. For more details on obtaining overseas drugs, you can consult the customer service staff.
Vericiguat's effects
Veliciguat is indicated to reduce the risk of cardiovascular death and heart failure (HF) hospitalization in adults with symptomatic chronic heart failure and an ejection fraction less than 45% who are hospitalized for heart failure or require outpatient intravenous diuretics. Vericiguat is a stimulator of soluble guanylate cyclase (sGC), a second messenger cGMP (cyclic guanosine monophosphate) that plays a role in regulating vascular tone, cardiac contractility, and cardiac remodeling.
Vericiguat is the first soluble guanylate cyclase (sGC) agonist developed to treat patients with worsening chronic heart failure. The trial results show that (vericiguat) can improve the patient's disease progression, reduce the patient's composite endpoint risk of heart failure hospitalization and death from cardiovascular causes, and significantly improve their quality of life. The launch of this drug has brought new treatment options and options to many heart failure patients.
Recommended related articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)